Biological and molecular basis of human breast cancer

作者: Jose Russo , Xiaoqi Yang , Yun-Fu Hu , Betsy A Bove , Yajue Huang

DOI: 10.2741/A335

关键词:

摘要: Human breast cancer remains the most common malignancy in American women. The ultimate cure of this disease relies on a better understanding mechanisms underlying initiation and progression disease. neoplastic transformation HBEC vitro represents successful model for obtaining knowledge molecular biological alterations that may contribute to tumorigenic mechanisms. We have presented here current chemically transformed following aspects: 1. Factors affecting such as genetic predisposition differentiation status prior immortalization; 2. New targets studying mechanism cell immortalization telomerase activity differential expression cycle dependent genes well others recently isolated through cloning H-ferritin, calcium binding protein; 3. Epigenetic transformation; 4. association microsatellite instability specific loci chromosomes 11, 13, 16 with 5. application microcell mediated chromosome transfer technique an approach testing functional role whose dysregulation or loss function transformation. Further efforts system will be directed determine roles identified changes mapping/cloning tumor suppressor senescence those reside 11 17.

参考文章(86)
Maomi Li, Z. F. Zhang, Victor E Reuter, Carlos Cordon-Cardo, Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. American Journal of Pathology. ,vol. 149, pp. 229- 235 ,(1996)
G F Saunders, D E Anderson, H Tsihira, M Genuardi, Distal deletion of chromosome Ip in ductal carcinoma of the breast. American Journal of Human Genetics. ,vol. 45, pp. 73- 82 ,(1989)
John I. Risinger, Thomas A. Kunkel, Richard D. Kolodner, Kenneth R. Tindall, Minoru Koi, J. Carl Barrett, C. Richard Boland, Warren E. Glaab, Asad Umar, Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Research. ,vol. 57, pp. 3949- 3955 ,(1997)
Lawrence A. Loeb, Mutator Phenotype May Be Required for Multistage Carcinogenesis Cancer Research. ,vol. 51, pp. 3075- 3079 ,(1991)
J L Weber, P E May, Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction American Journal of Human Genetics. ,vol. 44, pp. 388- 396 ,(1989)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
Rosemary A. Walker, J. Louise Jones, Stephen Chappell, Tom Walsh, Jacqueline A. Shaw, Molecular pathology of breast cancer and its application to clinical management Cancer and Metastasis Reviews. ,vol. 16, pp. 5- 27 ,(1997) , 10.1023/A:1005740222307
Andrew J Brenner, C Marcelo Aldaz, Chromosome 9p Allelic Loss and p16/CDKN2 in Breast Cancer and Evidence of p16 Inactivation in Immortal Breast Epithelial Cells Cancer Research. ,vol. 55, pp. 2892- 2895 ,(1995)
Lawrence A. Loeb, Cancer cells exhibit a mutator phenotype. Advances in Cancer Research. ,vol. 72, pp. 25- 56 ,(1997) , 10.1016/S0065-230X(08)60699-5